The expression levels of MRPs can serve as prognostic markers in cancer. High levels of MRP expression are often correlated with poor prognosis and reduced overall survival in patients. For example, high MRP1 expression in acute myeloid leukemia (AML) patients is associated with a lower response rate to chemotherapy and shorter survival times.
